Advertisement
The Lancet Diabetes and Endocrinology
Advanced Search

About The Lancet Diabetes & Endocrinology

Register
Subscribe
Submit

About the journal

Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

All original research articles are eligible for fast-track peer review for quick dissemination of practice-changing results and policy—papers can be published online within 4–8 weeks of submission. The journal is indexed/abstracted in MEDLINE/PubMed, Scopus, and in the Journal Citation ReportsTM.

Reputation and Impact

The Lancet Diabetes & Endocrinology has an Impact Factor of 25.340® (2019 Journal Citation Reports®, Clarivate Analytics 2020).

Information for authors

We consider any original research contribution that advocates change in or illuminates clinical practice, and informative reviews, on any topic connected with diabetes, diabetes-related non-communicable diseases, endocrinology, and metabolism. We have a special interest in studies on these topics of global health importance and with relevance to health in low-income and middle-income countries. We do not consider reports that include results of experiments on non-human animals. Figures and good quality photographs should be used to supplement and to enhance the text. If you require further clarification, the journal's editorial staff will be pleased to help (email [email protected]).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

About our content

We publish original research, reviews, and topical Comment about diabetes, endocrinology, and metabolism. Topics considered by the journal include—but are not limited to—diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

Manuscript submission

To submit your manuscript to The Lancet Diabetes and Endocrinology please visit: http://www.editorialmanager.com/thelancetde

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Marta Koch, Editor-in-Chief

Marta Koch began her research career at the Oncology Institute, Porto, Portugal. She was awarded a doctorate degree in biomedical sciences from research undertaken in Peter Carmeliet’s Lab at The University of Leuven, Belgium. Postdoctoral neurogenetics research was undertaken at the University of Leuven and at The Scripps Research Institute, Florida, USA. Marta has been a professional editor since joining the journal Cell in 2015. Her editorial experience extended through diverse basic science and translational research topics. She joined the Lancet group in 2018 as the inaugural Editor-in-Chief for EClinicalMedicine. She has been serving the diabetes and endocrinology communities as Editor-in-Chief of The Lancet Diabetes & Endocrinology.” since 2019.

Contact: [email protected]

David Holmes, Deputy Editor

After obtaining a PhD at Imperial College, London, David did postdoctoral work on diabetic nephropathy and prostate cancer before joining a biotechnology company, where he worked on cardiovascular and oncology research projects for 8 years. He began his career in publishing at BioMed Central, before moving to Nature Reviews Nephrology, and later to Nature Reviews Endocrinology. David joined The Lancet Diabetes & Endocrinology in 2017.

Contact: [email protected]

Neil Bennet, Senior Editor

Neil joined The Lancet Diabetes & Endocrinology in 2015. After his undergraduate degree, he completed a research Masters in Biomedical Sciences at the University of Edinburgh (investigating the genetics of prion disease) and a taught Masters in Science and Technology Studies. He has worked for The Lancet group since 2011.

Contact: [email protected]

About the advisory board

The International Advisory Board of the journal consists of key opinion leaders and researchers who lend their expertise to this journal. We are very grateful for their support and advice on editorial matters.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

Cover image volume 8, Issue 11
November 2020
Volume 8, Issue 11